Kos Biotechnology Partners announces strategic investment in Golden Age health to accelerate global access to rare disease therapies

Summary

Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President NEW YORK and ATHENS, Greece and SINGAPORE, 26 Oct. 2026 — Kos Biotechnology Partners ("Kos"), a global...